Cargando…
The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62/IGF2BP2-2 as a promoter of NAFLD and HCC?
Autores principales: | Simon, Yvette, Kessler, Sonja M, Bohle, Rainer M, Haybaeck, Johannes, Kiemer, Alexandra K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995267/ https://www.ncbi.nlm.nih.gov/pubmed/24173291 http://dx.doi.org/10.1136/gutjnl-2013-305736 |
Ejemplares similares
-
Individualised tailored assessment of therapeutic alternatives for HCC patients within the Milan criteria
por: Zhang, Ningning, et al.
Publicado: (2020) -
Reply to: Non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back?
por: Pavlides, Michael, et al.
Publicado: (2022) -
SARS-CoV-2: an opportunity for hospital pharmacy
por: Claramunt García, Raquel, et al.
Publicado: (2022) -
New-generation chromoendoscopy may increase confidence in the DISCARD2 study
por: Toyoshima, Osamu, et al.
Publicado: (2018) -
SARS-CoV-2 infection in ambulatory and hospitalised Spanish children
por: de Ceano-Vivas, María, et al.
Publicado: (2020)